Piramal Pharma Limited — Dividend/Bonus, 14-05-2025: Dividend

Piramal Pharma has approved the financial results for the quarter and year, posting a strong standalone net profit of Rs. 691.4 Cr and consolidated PAT of Rs. 91.13 Cr. The Board has proposed a final dividend of Rs. 0.14 per share, payable after shareholder approval post the AGM. Leadership changes include Mr. Amit Jain joining as Non-Executive Director and Mr. Jairaj Purandare’s re-appointment as Independent Director, ensuring continuity at the top. This dividend rewards shareholders following a solid performance year.